RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
RENOVORX, INC. (RNXT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.16 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 2.15M shares, a 120.14% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 12.00K shares, a 76.92% decline year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 355.56K shares, a 139.60% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 461.67K shares, a 355.97% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.85M shares, a 19.70% increase from fiscal 2024.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.54M shares, a 179.30% increase from fiscal 2023.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 552.10K shares, a 99.92% decline from fiscal 2022.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 724.94M shares, a 232064.09% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.15M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 2.16M shares 10-Q · filed 2026-08-13 | 2.52M shares derived: sum of 3 quarters · filed 2026-08-13 | 2.98M shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 12.00K shares 10-Q · filed 2026-05-14 | 367.56K shares derived: sum of 2 quarters · filed 2026-05-14 | 829.23K shares derived: sum of 3 quarters · filed 2026-05-14 | 1.81M shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 355.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 817.23K shares derived: sum of 2 quarters · filed 2026-03-30 | 1.79M shares derived: sum of 3 quarters · filed 2026-03-30 | 1.85M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 461.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 1.44M shares derived: sum of 2 quarters · filed 2025-11-13 | 1.49M shares 10-Q · filed 2025-11-13 | 1.64M shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 976.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 1.03M shares 10-Q · filed 2025-08-14 | 1.18M shares derived: sum of 3 quarters · filed 2025-08-14 | 1.28M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 52.00K shares 10-Q · filed 2025-05-15 | 200.40K shares derived: sum of 2 quarters · filed 2025-05-15 | 301.65K shares derived: sum of 3 quarters · filed 2025-05-15 | 479.65K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 148.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 249.65K shares derived: sum of 2 quarters · filed 2025-04-01 | 427.65K shares derived: sum of 3 quarters · filed 2025-04-01 | 1.54M shares 10-K · filed 2025-04-01 |
| 2024-09-30 | 101.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 279.25K shares derived: sum of 2 quarters · filed 2024-11-13 | 1.39M shares 10-Q · filed 2024-11-13 | 1.53M shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 178.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.29M shares 10-Q · filed 2024-08-13 | 1.42M shares derived: sum of 3 quarters · filed 2024-08-13 | 1.43M shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 1.11M shares 10-Q · filed 2024-05-10 | 1.25M shares derived: sum of 2 quarters · filed 2024-05-10 | 1.25M shares derived: sum of 3 quarters · filed 2024-05-10 | 1.36M shares derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | 131.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 139.25K shares derived: sum of 2 quarters · filed 2024-04-01 | 247.77K shares derived: sum of 3 quarters · filed 2024-04-01 | 552.10K shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 116.03K shares derived: sum of 2 quarters · filed 2023-11-13 | 420.35K shares 10-Q · filed 2023-11-13 | 724.86M shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 108.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | 412.85K shares 10-Q · filed 2023-08-16 | 724.86M shares derived: sum of 3 quarters · filed 2023-08-16 | 725.19M shares derived: sum of 4 quarters · filed 2023-08-16 |
| 2023-03-31 | 304.32K shares 10-Q · filed 2023-05-12 | 724.75M shares derived: sum of 2 quarters · filed 2023-05-12 | 725.08M shares derived: sum of 3 quarters · filed 2023-05-12 | 725.08M shares derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | 724.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 724.78M shares derived: sum of 2 quarters · filed 2023-03-31 | 724.78M shares derived: sum of 3 quarters · filed 2023-03-31 | 724.94M shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 334.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 334.99K shares derived: sum of 2 quarters · filed 2022-11-14 | 494.03K shares 10-Q · filed 2022-11-14 | 568.01K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 159.04K shares 10-Q · filed 2022-08-12 | 233.02K shares derived: sum of 3 quarters · filed 2022-08-12 | |
| 2022-03-31 | 159.04K shares 10-Q · filed 2022-05-13 | 233.02K shares derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2021-12-31 | 73.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 312.25K shares 10-K · filed 2022-03-30 | ||
| 2021-09-30 | 238.27K shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |